MindRhythm is a medical technology company focused on preventing neurological injury primarily caused by strokes. Founded by world-renowned experts with significant commercialization experience, MindRhythm's monitoring devices provide novel and real-time visibility to life-threatening situations prehospital allowing clinicians to intervene and prevent brain damage. Collaborating with the healthcare community, MindRhythm looks to apply the same systematic approach to reducing time to treatment in strokes that has been successfully implemented for heart attacks with the STEMI protocol.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/24/21 | $5,000,000 | Seed |
Aestus Capital Blue Fog Capital Corey Goodman, PhD David Lamond DCVC Franklin Berger Kyle York Perseverance Capital Management Pierre Lamond | undisclosed |
